BioPlus Acquisition Corp.

BioPlus Acquisition Corp. (Nasdaq: BIOS) is a blank-check company incorporated to identify and complete a business combination with a target in the life sciences and biotechnology sector. Sponsored by BioPlus Sponsor LLC, the company completed its initial public offering in 2021 and has been conducting an active search for a merger candidate in the healthcare and biopharma space. The company filed a Form 10-Q with the Securities and Exchange Commission on May 15, 2023, reflecting its continued status as an active public reporting entity at that time. To access full filing history, deal timelines, and SPAC analytics for BioPlus and the broader market, sign up for a SpacDesk account today.